Tag Archives: IRMagazine.com

SmallCap Public Relations – The Gift That Keeps On Giving

In a new post on IRMagazine.com, Jeffrey Goldberger of  KCSA Strategic Communications discussed “Public relations: The lifeline for clinical-stage micro-cap pharma companies.” According to Goldberger, the lack of news flow (especially microcap life science companies) results in lower stock price and trading volume which ultimately decreases a microcap companies ability to raise equity capital. There are three traditional IR chances for

Read more

Why Do Most Institutional Investors Avoid MicroCaps?

Derren Nathan, head of research at London-based broker Hybridan, recently shared an article on IRMagazine.com titled “How small caps can tackle investor prejudice.” In the post, Nathan shared these four reasons why most institutional investors avoid microcaps; Minimum Market Cap. “Many funds will have a minimum market cap requirement, and even where this is not an official policy, we often

Read more